The OPEN MINDS Executive Blueprint for Crisis ManagementBuilding Organizational Sustainability & Success in a Disrupted Health & Human Service Market
A 32-week program designed to help executive teams navigate the business, organizational, operational, and culture changes of a market in turbulence. The program, based on the seven-component OPEN MINDS executive blueprint, combines a series of 35 live educational web briefings with online technical assistance and a suite of on-demand resources.
District of Columbia Transmittal 19-14 – Removal Of Prior Authorization (PA) Requirements For Medication-Assisted Treatment (MAT) Drug Products
On May 15, 2019, the District of Columbia Department of Health Care Finance released this letter from the Medicaid Director. The letter pertains to the removal of Prior Authorization (PA) requirements for medication-assisted treatment (MAT) drug products. The purpose of the letter is to replace Transmittal No. 19-11 introducing Policy Number: HCDMA-19-001 which removes the PA requirements for MAT drug products that are prescribed and dispensed for the treatment of opioid use disorder and alcohol use disorder . . .